Search

everythinglearnresearchcommunity

for

Search:↓

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Researchers made two new compounds that could be used for medicine.

3α-androstanediol helps reduce age-related cognitive and mood declines in male rats, unlike testosterone.

Women with acne have lower levels of a specific hormone marker than women without acne.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Finasteride was successfully synthesized from Pregnadienolone acetate.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Finasteride safely reduces excessive hair growth in women.

A woman's rare adrenal tumor caused high testosterone and cortisol levels, which normalized after the tumor was removed.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Obese women with PCOS have lower vitamin D levels.

Finasteride and metformin both help treat PCOS, but using them together works best.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.